|
Market Closed -
Other stock markets
|
After market 01:14:25 pm | |||
| 3.444 EUR | -0.06% |
|
3.467 | +0.67% |
| Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
| Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Valneva SE provided revenue guidance for the full year 2023. For the year, the company expected total revenues and other income between 220 million and 260 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.03% | 512M | |
| +1.76% | 42.59B | |
| +8.03% | 40.65B | |
| +49.22% | 40.57B | |
| -12.36% | 26.77B | |
| +9.35% | 24.81B | |
| -24.19% | 18.17B | |
| +28.25% | 12.05B | |
| -3.20% | 11.7B | |
| +7.00% | 11.1B |
VALNEVA 
